Esther Segal

Summary

Affiliation: Tel Aviv University
Country: Israel

Publications

  1. ncbi Candida, still number one--what do we know and where are we going from there?
    Esther Segal
    Department of Human Microbiology, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel
    Mycoses 48:3-11. 2005
  2. ncbi Induced production of antifungal naphthoquinones in the pitchers of the carnivorous plant Nepenthes khasiana
    Haviva Eilenberg
    Department of Plant Sciences, The George S Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv 69978, Israel
    J Exp Bot 61:911-22. 2010
  3. ncbi Immunization protocols for use in animal models of candidiasis
    Esther Segal
    Department of Human Microbiology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    Methods Mol Biol 499:27-34. 2009
  4. ncbi Candida albicans metabolite affects the cytoskeleton and phagocytic activity of murine macrophages
    Ben Schindler
    Department of Human Microbiology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    Med Mycol 46:251-8. 2008
  5. ncbi Biomedical coatings based on chitin soluble extract for inhibition of fungal adhesion to polymeric surfaces
    Meital Zilberman
    Department of Biomedical Engineering, Tel Aviv University, Tel Aviv 69978, Israel
    J Biomed Mater Res A 81:392-8. 2007
  6. ncbi Infection of HEp2 epithelial cells with Candida albicans: adherence and postadherence events
    Hana Sandovsky-Losica
    Department of Human Microbiology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    FEMS Immunol Med Microbiol 46:470-5. 2006
  7. ncbi Efficacy of amphotericin B or amphotericin B-intralipid in combination with caspofungin against experimental aspergillosis
    Edward Sionov
    Department of Human Microbiology, Sackler School of Medicine, Tel-Aviv University, Ramat Aviv, Tel-Aviv 69978, Israel
    J Infect 53:131-9. 2006
  8. ncbi Experimental systemic murine aspergillosis: treatment with polyene and caspofungin combination and G-CSF
    Edward Sionov
    Department of Human Microbiology, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, 69978, Israel
    J Antimicrob Chemother 56:594-7. 2005
  9. ncbi Polyene and cytokine treatment of experimental aspergillosis
    Edward Sionov
    Department of Human Microbiology, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel
    FEMS Immunol Med Microbiol 39:221-7. 2003
  10. ncbi Effect of a chitin derivative in combination with cleaning and preservation solutions for contact lenses on adherence of fungi
    S Rotman
    Department of Ophthalmology, Assaf Harofe Medical Center, Zrifin, Israel
    Mycoses 46:90-5. 2003

Collaborators

  • M Zilberman
  • Edward Sionov
  • Hana Sandovsky-Losica
  • Haviva Eilenberg
  • Ben Schindler
  • Sonia Mendlovic
  • S Rotman
  • Smadar Pnini-Cohen
  • Shmuel Carmeli
  • Aviah Zilberstein
  • Yocheved Rahamim
  • E Sionov

Detail Information

Publications10

  1. ncbi Candida, still number one--what do we know and where are we going from there?
    Esther Segal
    Department of Human Microbiology, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel
    Mycoses 48:3-11. 2005
    ..A vast body of scientific literature, has been accumulated on these pathogens. A review of the literature and topics for further research are discussed...
  2. ncbi Induced production of antifungal naphthoquinones in the pitchers of the carnivorous plant Nepenthes khasiana
    Haviva Eilenberg
    Department of Plant Sciences, The George S Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv 69978, Israel
    J Exp Bot 61:911-22. 2010
    ....
  3. ncbi Immunization protocols for use in animal models of candidiasis
    Esther Segal
    Department of Human Microbiology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    Methods Mol Biol 499:27-34. 2009
    ..We focus on recent efforts with the Als family of cell wall proteins to serve as a model, and also offer immunization methods in candidiasis models that can be adapted to any antigen of the organism...
  4. ncbi Candida albicans metabolite affects the cytoskeleton and phagocytic activity of murine macrophages
    Ben Schindler
    Department of Human Microbiology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    Med Mycol 46:251-8. 2008
    ..In conclusion, our data indicate that a C. albicans metabolite affects phagocytic activity of macrophages, probably by alterations in their cytoskeleton...
  5. ncbi Biomedical coatings based on chitin soluble extract for inhibition of fungal adhesion to polymeric surfaces
    Meital Zilberman
    Department of Biomedical Engineering, Tel Aviv University, Tel Aviv 69978, Israel
    J Biomed Mater Res A 81:392-8. 2007
    ..Hence, our new coatings may lead to a new generation of medical devices with surfaces that can prevent fungal adhesion...
  6. ncbi Infection of HEp2 epithelial cells with Candida albicans: adherence and postadherence events
    Hana Sandovsky-Losica
    Department of Human Microbiology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    FEMS Immunol Med Microbiol 46:470-5. 2006
    ..Our results show that the interaction of C. albicans with HEp2 cells is, not unexpectedly, complex, and involves changes in the host cell that may be related to the effect of Candida-secreted biomolecules...
  7. ncbi Efficacy of amphotericin B or amphotericin B-intralipid in combination with caspofungin against experimental aspergillosis
    Edward Sionov
    Department of Human Microbiology, Sackler School of Medicine, Tel-Aviv University, Ramat Aviv, Tel-Aviv 69978, Israel
    J Infect 53:131-9. 2006
    ..CONCLUSION: The successful results obtained in the experimental animal model of this study may possibly open the way to more effective management of aspergillosis in humans...
  8. ncbi Experimental systemic murine aspergillosis: treatment with polyene and caspofungin combination and G-CSF
    Edward Sionov
    Department of Human Microbiology, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, 69978, Israel
    J Antimicrob Chemother 56:594-7. 2005
    ..CONCLUSIONS: The successful results obtained in the experimental model may possibly open the way to more effective management of aspergillosis in humans...
  9. ncbi Polyene and cytokine treatment of experimental aspergillosis
    Edward Sionov
    Department of Human Microbiology, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel
    FEMS Immunol Med Microbiol 39:221-7. 2003
    ..7 days) and to treatment with polyenes alone (up to 51.5% survival, MST 18.4 days). These data indicate that combination therapy could be beneficial for management of disseminated aspergillosis in humans...
  10. ncbi Effect of a chitin derivative in combination with cleaning and preservation solutions for contact lenses on adherence of fungi
    S Rotman
    Department of Ophthalmology, Assaf Harofe Medical Center, Zrifin, Israel
    Mycoses 46:90-5. 2003
    ....